Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Risk-Prediction Model for Ischemic Stroke in Patients Hospitalized With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])
Kay Lee Park, Andrzej Budaj, Robert J. Goldberg, Frederick A. Anderson, Giancarlo Agnelli, Brian M. Kennelly, Enrique Gurfinkel, Gordon FitzGerald, Joel M. Gore (2012). Risk-Prediction Model for Ischemic Stroke in Patients Hospitalized With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]). , 110(5), DOI: https://doi.org/10.1016/j.amjcard.2012.04.040.
Article324 days agoComparison of Utilization of Statin Therapy at Hospital Discharge and Six-Month Outcomes in Patients With an Acute Coronary Syndrome and Serum Low-Density Lipoprotein ≥100 mg/dl Versus <100 mg/dl
Frederick A. Spencer, Robert J. Goldberg, Joel M. Gore, Keith A.A. Fox, Álvaro Avezum, Giancarlo Agnelli, Leonard Kritharides, Frederick A. Anderson, Shaun G. Goodman, Gordon FitzGerald, Jeanna Allegrone, David Brieger (2007). Comparison of Utilization of Statin Therapy at Hospital Discharge and Six-Month Outcomes in Patients With an Acute Coronary Syndrome and Serum Low-Density Lipoprotein ≥100 mg/dl Versus <100 mg/dl. , 100(6), DOI: https://doi.org/10.1016/j.amjcard.2007.04.023.
Article324 days agoOutcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes
Omar Dabbous, Frederick A. Anderson, Joel M. Gore, Kim A. Eagle, Keith A.A. Fox, Rajendra H. Mehta, Robert J. Goldberg, Giancarlo Agnelli, Philippe Gabríel Steg (2007). Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. , 94(2), DOI: https://doi.org/10.1136/hrt.2006.105783.
Article324 days ago